Castle Biosciences Statistics Share Statistics Castle Biosciences has 29.01M
shares outstanding. The number of shares has increased by 4.09%
in one year.
Shares Outstanding 29.01M Shares Change (YoY) 4.09% Shares Change (QoQ) 1.26% Owned by Institutions (%) 90.43% Shares Floating 28.17M Failed to Deliver (FTD) Shares 369 FTD / Avg. Volume 0.07%
Short Selling Information The latest short interest is 1.29M, so 4.47% of the outstanding
shares have been sold short.
Short Interest 1.29M Short % of Shares Out 4.47% Short % of Float 5.12% Short Ratio (days to cover) 1.34
Valuation Ratios The PE ratio is 40.57 and the forward
PE ratio is -12.33.
Castle Biosciences's PEG ratio is
-0.31.
PE Ratio 40.57 Forward PE -12.33 PS Ratio 2.23 Forward PS 2.1 PB Ratio 1.62 P/FCF Ratio 20.26 PEG Ratio -0.31
Financial Ratio History Enterprise Valuation Castle Biosciences has an Enterprise Value (EV) of 646.87M.
EV / Sales 1.95 EV / EBITDA 16.96 EV / EBIT 9.97 EV / FCF 17.7
Financial Position The company has a current ratio of 7.29,
with a Debt / Equity ratio of 0.06.
Current Ratio 7.29 Quick Ratio 7.13 Debt / Equity 0.06 Debt / EBITDA 0.69 Debt / FCF 0.72 Interest Coverage 15.03
Financial Efficiency Return on Equity is 4% and Return on Invested Capital is 1.52%.
Return on Equity 4% Return on Assets 3.43% Return on Invested Capital 1.52% Revenue Per Employee $423.56K Profits Per Employee $23.27K Employee Count 784 Asset Turnover 0.63 Inventory Turnover 7.4
Taxes Income Tax 3.32M Effective Tax Rate 15.39%
Stock Price Statistics The stock price has increased by -25.85% in the
last 52 weeks. The beta is 1.07, so Castle Biosciences's
price volatility has been higher than the market average.
Beta 1.07 52-Week Price Change -25.85% 50-Day Moving Average 19.69 200-Day Moving Average 22.12 Relative Strength Index (RSI) 57.33 Average Volume (20 Days) 521,806
Income Statement In the last 12 months, Castle Biosciences had revenue of 332.07M
and earned 18.25M
in profits. Earnings per share was 0.66.
Revenue 332.07M Gross Profit 271.86M Operating Income 8.67M Net Income 18.25M EBITDA 38.14M EBIT 22.14M Earnings Per Share (EPS) 0.66
Full Income Statement Balance Sheet The company has 119.71M in cash and 26.34M in
debt, giving a net cash position of 93.36M.
Cash & Cash Equivalents 119.71M Total Debt 26.34M Net Cash 93.36M Retained Earnings -200.13M Total Assets 544.73M Working Capital 297.78M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 64.87M
and capital expenditures -28.33M, giving a free cash flow of 36.54M.
Operating Cash Flow 64.87M Capital Expenditures -28.33M Free Cash Flow 36.54M FCF Per Share 1.32
Full Cash Flow Statement Margins Gross margin is 81.87%, with operating and profit margins of 2.61% and 5.49%.
Gross Margin 81.87% Operating Margin 2.61% Pretax Margin 6.49% Profit Margin 5.49% EBITDA Margin 11.48% EBIT Margin 2.61% FCF Margin 11%
